1SCHLERFER S J,KELLER S E,BOND R N,et al.Major depressive disorder and immunity.Role of age,sex,severity,and hospitalization[J].Archives of General Psychiatry,1989,46(1):81-87.
2SCHEIFER S J,KELLER S E.Immunity in young adults with major depressive disorder[J].Am J Psychiatry,1996,153:477-482.
3MAES M,BOSMANS E,De JONGH R.et al.Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression[J].Cytokine,1997,9 (11):853-858.
4YOUNG E A,MIDGLEY A R,CARLSON N E,et al.Alteration in the hypothalamic-pituitary-ovarian axisin depressed women[J].Arch Gen Psychiatry,2000,57:1157-1162.
5RASGON N L,ALTSHULER L L,FAIRBANKS L.Estrogen therapy for depression[J].Am J Psychiatry,2001,158(10):1738.
6GALLO J J,ARMERNIAN H K.Major depression and cancer:the 13 -year follow-up of the Baltimore epidemiologic catchment area sample (United States)[J].Cancer Causes Control,2000,11 (8):751-758.
7PARASKA K,BENDER C M.Cognitive dysfunction following adjuvant chemotherapy for breast cancer:two case studies[J].Oncol Nurs Forum,2003,30(3):473-478.
8BADGER T A,BRADEN C J.Depression burden,self-help interventions,and side effect experience in women receiving treatment for breast cancer[J].Oncol Nurs Forum,2001,28(3):567-574.
9KANO Y,OKAMURA H.Mental adjustment to first recurrence and correlated factors in patients with breast cancer[J].Brest Cancer Res Treat,2001,67(3):255-262.
10MARK A,KENNETH J.Mind-body effect:insulinlike growth factor-1;clinical depression;and breast,prostate,and other cancer risk-an unmeasured and masked mediator of potential significance?[J].Urology,2002,59(4):4-8.
